Last week when I posted an updated list of events, I also wrote: "Will potentially be revised again soon once the Resverlogix May fact sheet is posted and the American Diabetes Association meeting program is available"
ADA program is now available. Resverlogix has one abstract that I found, to be presented on Monday June 10th.
"474-P - Apabetalone (RVX-208) Attenuates an Inflammatory Milieu that Enhances Adhesion of Monocytes to Endothelial Cells in Type 2 Diabetes Mellitus with Cardiovascular Disease Patients"
